Page last updated: 2024-10-31

mianserin and Dermatitis, Atopic

mianserin has been researched along with Dermatitis, Atopic in 1 studies

Mianserin: A tetracyclic compound with antidepressant effects. It may cause drowsiness and hematological problems. Its mechanism of therapeutic action is not well understood, although it apparently blocks alpha-adrenergic, histamine H1, and some types of serotonin receptors.
mianserin : A dibenzoazepine (specifically 1,2,3,4,10,14b-hexahydrodibenzo[c,f]pyrazino[1,2-a]azepine) methyl-substituted on N-2. Closely related to (and now mostly superseded by) the tetracyclic antidepressant mirtazapinean, it is an atypical antidepressant used in the treatment of depression throughout Europe and elsewhere.

Dermatitis, Atopic: A chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. It is manifested by lichenification, excoriation, and crusting, mainly on the flexural surfaces of the elbow and knee. In infants it is known as infantile eczema.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zirwas, MJ1

Other Studies

1 other study available for mianserin and Dermatitis, Atopic

ArticleYear
Dramatic response to chloroquine and mirtazapine for recalcitrant atopic dermatitis.
    Dermatitis : contact, atopic, occupational, drug, 2006, Volume: 17, Issue:4

    Topics: Adolescent; Antimalarials; Chloroquine; Dermatitis, Atopic; Drug Therapy, Combination; Histamine H1

2006